KLRS
#3960
Kalaris Therapeutics, Inc. - Common Stock
4.5 5 USD
+0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+2.94%
Variación mensual
+0.22%
Variación en los últimos 6 meses
-55.52%
Cambio anual
-55.52%
Cierres anteriores
4.4 2
Open
4.5 5
Mínimo
4.5 5
High
4.5 5
Volumen
2
Financials
- Market Capitalization 108.25 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3953 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.86 USD | -2.11% | -10.58% | +3.33% | -36.95% | 106.58 M USD | ||
| 3957 |  ICCC ImmuCell Corporation - Common Stock | 11.62 USD | +4.87% | +12.38% | +21.17% | +79.60% | 105.12 M USD | ||
| 3973 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.93 USD | +0.17% | -1.33% | +2.24% | -1.50% | 101.87 M USD | ||
| 3975 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.70 USD | -22.02% | -21.30% | -41.98% | -34.87% | 98.43 M USD |